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Due to their direct antiviral activity, Mx proteins play a main role in the 
response mediated by the type I interferon against viral infections. The study of 
the farmed fish gilthead seabream Mx genes is especially interesting, since this 
species displays an unusually high natural resistance to viral diseases, becoming 
a potential asymptomatic carrier and/or reservoir for several viruses pathogenic 
to other fish species. Gilthead seabream has three Mx proteins (Mx1, Mx2 and 
Mx3) that, separately, display antiviral activity against a wide range of viruses, 
showing interesting differences in their antiviral specificities. 
 
In this work, the possible synergy between the three Mx isoforms has been 
studied using in vitro systems, consisting of permanently transfected CHSE-214 
cells expressing two or the three gilthead seabream Mx proteins. The antiviral 
activity of these Mx combinations has been tested against the infection by the 
Infectious Pancreatic Necrosis Virus (IPNV), the Viral Haemorrhagic 
Septicaemia Virus (VHSV) and the European Sheatfish Virus (ESV) in cells 
inoculated at 0.1 and 0.01 multiplicity of infection (MOI). The antiviral effect 
was evaluated by viral titration (TCID50 method). 
 
Interestingly, a positive synergistic effect in the antiviral activity against ESV 
was observed when Mx2 and Mx3 were combined, and this effect was 
intensified when the three isoforms were present in these cells. In contrast, the 
presence of more than one Mx isoform interfered with the antiviral activity 
against IPNV and VHSV showed by the Mx proteins expressed separately. 
Furthermore, Mx2 combined with Mx3, and the combination of the three Mx 
proteins exerted a negative synergistic effect against IPNV infection. 
Specifically, the viral titres were significantly higher in Mx expressing cells 
than in control cells. In the same way, in Mx1 and Mx2 expressing cells 
infected with VHSV the viral replication was also increased. 
 
These results suggest the interaction between Mx isoforms, in which the 
expression level of each isoform might be an important factor, and support the 
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idea of finely tuned mechanisms controlling the antiviral activity of Mx 
proteins. 
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